A groundbreaking shift in Canadian drug policy has taken place, as the authorities permit the availability of psilocybin mushrooms for therapeutic applications. Previously, these substances were strictly restricted, but a increasing body of studies suggests they potentially offer benefits for emotional illnesses like PTSD. The new policy represents